key: cord-0887139-piy1wj0h
authors: Fahmy, Dina Hassan; El‐Amawy, Heba Saed; El‐Samongy, Marwa Ahmed; Foud, Aya Ashraf; Soliman, Sarah Hamdy; El‐Kady, Aya; Farnetani, Francesca; Conti, Andrea; Zoeir, Ahmed; Eissa, Ahmed; Eissa, Radwa; Puliatti, Stefano; Sighinolfi, Maria Chiara; Rocco, Bernardo; Pellacani, Giovanni
title: COVID‐19 and Dermatology: A Comprehensive Guide for Dermatologists
date: 2020-05-19
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.16545
sha: 27a6fccfc5b362815ff9f10a9676e5a14547939e
doc_id: 887139
cord_uid: piy1wj0h

As of the 11(th) of March, the world health organization (WHO) declared Coronavirus disease‐2019 (COVID‐19) as a pandemic disease caused by SARS‐CoV‐2 (previously known as 2019‐nCOV) (1,2). By the 19(th) of April, 2,241,778 confirmed patients were reported worldwide with 152,552 COVID‐19 related deaths (3). The COVID‐19 pandemic represents the most serious health crisis facing the modern world resulting in unprecedented efforts to contain this pandemic and its consequences (1).

As of the 11 th of March, the world health organization (WHO) declared Coronavirus disease-2019 (COVID-19) as a pandemic disease caused by SARS-CoV-2 (previously known as 2019-nCOV) (1, 2) . By the 19 th of April, 2,241,778 confirmed patients were reported worldwide with 152,552 COVID-19 related deaths (3) . The COVID-19 pandemic represents the most serious health crisis facing the modern world resulting in unprecedented efforts to contain this pandemic and its consequences (1) .

All the coronaviruses (CoVs) belong to the "Coronaviridae" family, which, consists of a group of enveloped, positive-sense, and single-stranded RNA viruses with an extended field of original roots. The CoVs are genotypically and serologically classified into four genera: α, β, γ, and δ-CoVs, of which, the α and β CoVs are capable of infecting humans (4) . SARS-CoV-2 was recognized as a member of β-CoVs with a genome sequence similar to the bat CoV and SARS-CoV-1 (5, 6) . SARS-CoV-2 is characterized by the presence of specific spike glycoprotein that shows strong binding affinity to the Angiotensinogen Converting Enzyme 2 (ACE2) receptors; however, it is worth mentioning that SARS-CoV-2 has 10-20 folds higher binding affinity to ACE2 receptors compared to SARS-CoV-1 (6, 7) . Generally, ACE2 may be expressed in different parts of the human body including the lung, small intestine, colon, duodenum, kidney, testis, gallbladder, heart, esophagus, and urinary bladder, rendering these organs a potential target for the SARS-CoV-2 (6, 8) . Interestingly, an old report by Hamming I et al (9) , demonstrated the presence of ACE2 in the basal cell layer of the epidermis continuing to the basal cell layer of the hair follicles, the smooth muscle cells that enclose the sebaceous glands, and the eccrine glands. In the same setting, Goren A et al (10) , postulated a hypothesis that androgen receptors may play a role in the severity of the COVID-19 patients. This hypothesis was based on the disproportionate prevalence of severe COVID-19 among children and adult females compared to adult males. Besides, the ACE2 activity have shown to decrease with the reduction of the androgen hormones (10) . However, this theory is not yet proven.

The SARS-CoV-2 is a highly contagious disease that is characterized by a basic reproductive value (R0) of 2-3.5, reflecting the capability of one patient to transmit the disease to 2-3 other persons (11) . According to the WHO, SARS-CoV-2 is transmitted through respiratory droplets of

This article is protected by copyright. All rights reserved.

infected person in either a direct (close contact with infected person) or indirect (fomites surrounding the infected persons or tools used during examination such as dermatoscope) (12, 13) .

Finally, hidden transmission from asymptomatic carriers was reported (14) .

There is a broad spectrum of manifestations in COVID-19 patients (fever, dry cough, dyspnea and myalgia with headache, nausea and diarrhea being less frequent manifestations) (1). The presentations are categorized into 4 categories: Asymptomatic patients (1%); mild to moderate (81%); severe (14%); and critically ill patients (5%). The overall mortality rate is 2.3% (15) .

Several viral infections are characterized by the presence of related cutaneous manifestations (16) .

A recent Italian study of 88 COVID-19 patients showed that 20.4% of the patients demonstrated cutaneous manifestation in the form of erythematous rash, urticaria, and chickenpox-like vesicles mainly in the trunk with little or no itching. Furthermore, the authors reported that those skin lesions were not correlated with disease severity (17) . Similarly, Henry D et al (18) , reported that COVID-19 patients may present with urticarial eruption without any respiratory symptoms (cough or fever). On the same hand, a COVID-19 patient was misdiagnosed as dengue in Thailand as the principal presentations were skin rash with petechiae and low platelet count (19) . In these settings, dermatologists should pay particular consideration to patients presenting with viral-like skin rash so as not to miss COVID-19 cases (20) .

Generally, skin is considered a part of the immune system as it acts as a shield against different environmental stimuli (21) . In this setting, compromising the integrity of this barrier by lacerations, scratching, needling, pre-existing infections or diseases of skin, wounds, and burns may facilitate the invasion by micro-organisms (22) . Therefore, dermatological patients may be at higher risk of SARS-CoV-2 either due the loss of the skin integrity by dermatological diseases or the immunosuppressive therapy used in the management of some diseases (23, 24) .

Many patients may take advantage of the quarantine period to do some cosmetic procedures considering that the quarantine period is an appropriate opportunity for healing and downtime of the skin; however, it should be noted that fractionated ablative laser resurfacing may result in

This article is protected by copyright. All rights reserved. narrow columns of dermal injuries allowing for potential infection (25) . Additionally, Microneedling especially home ones may carry high risk of infection and viral autoinoculation (26) .

Since the start of COVID-19 pandemic, many measures and protocols have been taken to reduce the risk of spread of infection, to flatten the peak of the epidemic curve, and to prepare the different healthcare facilities to the expected surge of COVID-19 patients (27, 28) . Based on the Chinese experience, only urgent dermatological surgeries should be performed, the capacity of the outpatient clinics should be reduced, all patients should be screened at the clinic entrance for fever or history of travel to endemic areas, and all patients should be wearing masks; however, it is worth mentioning that sometimes the use of masks for patients may be difficult as most of the high-risk carcinomas are located in face region. Furthermore, doctors should wear mask, goggles, protective suits, head caps and gloves (29) (30) (31) . Generally, the majority of the dermatological outpatient visits are elective, thus, it is recommended to cancel all non-urgent visits and only urgent outpatient visits (including surgeries for malignancies) should be performed provided that adequate protective measures are followed (23, 27, 32, 33) . Furthermore, the authors recommended that practitioners at risk of COVID-19 (60 years or older, immunocompromised, pregnant, and comorbidities) should avoid contact with patients (32). On the same hand, hospital admission should only be preserved for patients with severe skin disease not responding to outpatient treatment (27) . In conclusion, COVID-19 has dramatically affected the dermatological practice; however, dermatologists should pay careful attention not to compromise (by cancelling or deferring) urgent and high-risk cases.

One of the medical technologies that gained interest during the current pandemic is the telemedicine that allows the dermatologists to diagnose the patients remotely and prescribe proper treatment without compromising the social distancing role (34) (35) (36) (37) (38) . There are two types of consultation in teledermatology either synchronous (which include real time interaction between the patient and the physician) or asynchronous (in which the patients data are stored and then reviewed later by the physician) (36) . Interestingly, smart phone technology (especially whatsapp) has been proposed to overcome the lack of teledermatology equipment in most of healthcare facilities; however, it may limited by the poor video and images quality, and medicolegal and privacy issues (38) .

This article is protected by copyright. All rights reserved. remote teaching of medical students and residents through online lectures, seminars, and case discussion is safer compared to the classic methods during this critical time (39) .

Immunosuppressants are mainly used in the dermatological practice for the management of autoimmune and inflammatory diseases such as psoriasis, atopic dermatitis, systemic lupus erythematosus, dermatomyositis, pemphigus vulgaris and pyoderma gangrenosum (40, 41) .

However, their use during the current pandemic is a matter of debate as a result of lack of evidence about COVID-19 risk in immunosuppressed patients (42, 43) . Conforti C et al (42) , suggested that these immunosuppressant drugs may be associated with higher risk of opportunistic infections as they weaken the immune response. This suggestion was based on previous reports about the increased risk of swine influenza A (H1N1) infection or death in psoriatic patients using immunosuppressant drugs (44, 45) . Therefore, Conforti C et al (42) due to the associated comorbidities (insulin dependent type-2 diabetes and systemic sclerosis associated interstitial lung disease); however, the patient showed just mild symptoms for 10 days

This article is protected by copyright. All rights reserved. and the tocilizumab was resumed 4 days after the negative SARS-CoV-2 test (48) . Several other authors reported that a case-by-case evaluation may be more convenient as some of these biologics may not be harmful during the COVID-19 pandemic but even theoretically beneficial and their cessation may be associated with the development of anti-drug antibody (49) (50) (51) .

Generally, the recommendation for the immunomodulators use should be based on the mechanism of action of each of drug and its associated risk of infection (52, 53) . For example, Tumor Necrosis Factor-α (TNF-α) inhibitors is associated with similar risk of infection by seasonal and H1N1 influenza as compared to normal population (54); however, it was associated with up to 7% increased rate of overall infection compared to placebo (except for etanercept) (52) .

Theoretically, TNF-α inhibitors may play a protective role through modulation of inflammation and decreasing alveolar damage as the pneumonia caused by COVID-19 is usually associated with cytokine storm with increased levels of TNF-α and other cytokines (55, 56) . Considering atopic dermatitis patients with positive tests for COVID-19, careful risk assessment should be performed before cessation of immunomodulators as the abrupt stoppage of these drugs

This article is protected by copyright. All rights reserved. may be associated with exacerbations of the condition and comorbidities (including asthma, kidney disease and allergy), and topical therapy should be considered during the pause period (60) .

Cancer patients may be at a higher risk for the development of infectious disease with a 3.5 folds increased risk of developing COVID-19 adverse events including the need for mechanical ventilation and/or death due to their immunocompromised state that is associated to the nature and the aggressiveness of the neoplasm and the anti-cancer treatment (1). Only one report in the literature discussed the adherence of patients with advanced basal cell carcinoma to hedgehog inhibitors during the COVID-19 pandemic. The report included 37 patients, of which, only three patients interrupted the treatment as a result of severe comorbidities, while all the remaining patients either attended the outpatient clinic for the monthly prescription or used a modified treatment scheme to prolong their treatment. It is noteworthy to mention that there is no evidence against the continuation of these drugs during the current pandemic (61) .

On the other hand, immune checkpoint inhibitors (ICIs) are considered one of the promising treatment options for patients with advanced melanoma (62) . Noteworthy, the susceptibility of patients taking ICIs to infectious diseases has not been thoroughly discussed in the literature. The use of ICIs during the current pandemic may represent a matter of concern as a result of the potential overlap between the SARS-CoV-2 related pneumonia and the pulmonary toxicity of the ICIs (however, it should be mentioned that this pneumological toxicity is a rare event ranging from 2.5-5% in case of ICIs monotherapy to 7-10% in case of combination therapy). Furthermore, the synergism between the ICIs mechanism of action and the SARS-CoV-2 pathogenesis may potentiate the pathological effect of COVID-19. In this setting, the use of ICIs should be carefully weighted according to a case-by-case scenario (63) . Considering squamous cell carcinoma of the skin, the same precautions (discussed before) should be followed if immunomodulators is considered for treatment.

Arora G et al (64) , raised the concern that patients with rheumatologic skin disease may be at higher risk for COVID-19 either due to the disease itself or its medications. Furthermore, some rheumatological diseases such as rheumatoid arthritis may be associated with new-onset or reactivation of arthritis during the remission following some viral infections (including coronavirus) (64) .

This article is protected by copyright. All rights reserved.

Considering sexually transmitted diseases (STDs), the quarantine and social distancing measures may not only affect physical and psychosocial health of the individuals but also the sexual health, where, these measures may lower the opportunity for casual sex that in turn might reduce the incidence of STDs such as syphilis, gonorrhea and chlamydia in the future (65) . Furthermore, it is also recommended not to cancel the visits of STD patients (it can be performed using teledermatology or virtual clinics) to avoid the consequences including the further spread of the disease.

Several skin complications may result from the prolonged use of personal protective equipment as a result of hyperhydration effect, friction, and allergic contact reactions (24) . The prevalence of skin damage resulting from wearing protective equipment was 97.0% among healthcare workers including lesions of the nasal bridge (83.1%), hands, cheek and forehead (66) . Furthermore, excessive hand washing with detergents and/or disinfectants may cause contact dermatitis (24) . In these settings, a consensus of Chinese experts on the protection of the skin and mucous membranes was released recommending that hand washing or gloves decontamination should be limited to the following moments; before touching the patients or any aseptic procedure and after exposure to body fluids, touching the patient or any of the patients' items. Furthermore, they recommended the use of ethanol for hand hygiene and applying hand cream following each time of hand hygiene if possible. However, in case of latex gloves it is recommended to wear a cotton gloves below and to use moisturizers with topical glucocorticoid cream. Similarly, it is recommended to use a properly fitting mask and goggles and apply moisturizers or gel at contact areas (67) . Furthermore, Yin Z et al (68) , suggested the use of double protection (benzalkonium chloride paste on the nasal bridge followed by hydrocolloid dressing) before wearing the N95 masks.

Many vaccines had been injected intralesionally to treat warts, as BCG, which, results in IL-12 increase and IL-4 decrease and MMR vaccine, which, is capable of stimulating the cell-mediated and humoral immune response (69) . Children are characterized by significantly lower risks for developing severe form of COVID-19 with lower mortality rates compared to adult population and this may be due to the global active viral immunization of children (70, 71) . Based on these observations, the vaccines that have been used to treat viral skin lesions can theoretically be a

This article is protected by copyright. All rights reserved. potential treatment option of COVID-19; however, further studies are required to confirm the role of vaccines in COVID 19 prophylaxis and/or treatment.

There is a strong rationale for the use of antimalarial drugs (chloroquine [CQ] and hydroxychloroquine) to treat infections. These drugs are considered to be immunomodulators as they reduce T cell activation, suppress the toll-like receptors (TLR) signaling, and inhibit proinflammatory cytokines production by T cells and B cells (72) . In animal studies, CQ was capable of Inhibiting SARS-CoV spread either prior to or after infection, suggesting that CQ might have both prophylactic and therapeutic advantages (73) . In this setting, Chinese experts recommend that patients with COVID-19 (mild, moderate or severe) and without contraindications to chloroquine should be treated with 500 mg chloroquine twice daily for ten days (74). However, these drugs should be used with caution and under medical supervision to avoid macular retinopathy and cardiovascular disorders that may be life-threatening (75) .

Ivermectin is an FDA-approved antiparasitic drug that is characterized by anti-viral activity. An ex-vivo study demonstrated that ivermectin is able to produce approximately 5000 folds reduction in the viral RNA in the treated cells compared to the control samples. These promising results should promote in-vivo studies (76).

These recommendations are based on the findings of the current review, the protocols in the dermatology department in our universities, and the measures recommended by CDC (center for disease control and prevention). Table 1 shows a summary of recommendations based on the findings of the current review. 

This article is protected by copyright. All rights reserved.

disease (64) associated with new-onset or reactivation of arthritis during the remission period of rheumatoid arthritis.

-It is recommended to use teledermatology to continue the consultations of sexually transmitted diseases to avoid the further spread of these disease 

This article is protected by copyright. All rights reserved.

COVID-19 and Urology: A Comprehensive Review of the Literature

World Health Organization

World Health Organization

The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic 1 options 2 Downloaded from

A new coronavirus associated with human respiratory disease in China

Structure analysis of the receptor binding of 2019-nCoV

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

WHAT DOES ANDROGENETIC ALOPECIA HAVE TO DO WITH COVID-19? AN INSIGHT INTO A POTENTIAL NEW THERAPY

Apr 8];e13365

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations

Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day! J Eur Acad Dermatology Venereol

Presumed Asymptomatic Carrier Transmission of COVID-19

Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention

Cutaneous viral infections

Cutaneous manifestations in COVID-19: a first perspective

Urticarial eruption in COVID-19 infection

COVID-19 can present with a rash and be mistaken for Dengue

Viral exanthem in COVID-19, a clinical enigma with biological significance. J Eur Acad Dermatology Venereol

3D skin models for 3R research: The potential of 3D reconstructed skin models to study skin barrier function

Bacterial Skin and Soft Tissue Infections in Adults: A Review of Their Epidemiology, Pathogenesis, Diagnosis, Treatment and Site of Care

Emergency management for preventing Accepted Article This article is protected by copyright. All rights reserved. and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department

Covid-19 pandemic and the skin -What should dermatologists know? Clin Dermatol

A case of herpes simplex virus reactivation after fractional ablative carbon dioxide laser to treat a burn scar

Unintended widespread facial autoinoculation of varicella by home microneedling roller device

Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital. J Eur Acad Dermatology Venereol

Priorities for global health community in COVID-19 pandemic

What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus

What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China. J Eur Acad Dermatology Venereol

Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease

Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatology visits

Ethical Outpatient Dermatology Care During the Coronavirus (COVID-19) Pandemic

COVID-19: Challenges and opportunities for dermatology response

Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action. JMIR public Heal Surveill

Teledermatology: a useful tool to fight COVID-19

Telehealth: Helping Your Patients and Practice Survive and Thrive During the COVID-19 Crisis with Rapid Quality Implementation

WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side

Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances. J Eur Acad Dermatology Venereol

Prats-Caelles I. Manejo práctico de inmunosupresores en dermatología

Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis. J Eur Acad Dermatology Venereol

COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

Guidance on the use of biologic agents during COVID-19 outbreak

Influenza H1N1 infection in a patient with psoriatic arthritis in treatment with Adalimumab: A case report

Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab

Should patients stop their biologic treatment during the COVID-19 pandemic

Biologic therapy for psoriasis during the covid-19 outbreak is not a choice

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Antipsoriatic treatments during COVID-19 outbreak

Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

Immunomodulator/Immunosuppressant Use in Dermatology

Should biologics for psoriasis be interrupted in the era of COVID-19?

Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic

Anti-tumor necrosis factor therapy and influenza: Keeping it in perspective

Clinical features of patients infected Accepted Article This article is protected by copyright. All rights reserved. with 2019 novel coronavirus in Wuhan

Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice

A randomized, open-label, controlled trial for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia

Reducing mortality from 2019-nCoV: host-directed therapies should be an option

Clinical management of severe acute respiratory infection when COVID-19 is suspected

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis

Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment

Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

Outbreak and Rheumatologic Skin Diseases

Apr 8];e13357

The Impacts of Isolation Measures Against SARS-CoV-2 Infection Accepted Article This article is protected by copyright

Skin damage among healthcare workers managing coronavirus disease-2019

Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019

Covid-19: Countermeasure for N95 mask-induced pressure sore. J Eur Acad Dermatology Venereol

Evolving role of immunotherapy in the treatment of refractory warts

Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China

Routine childhood immunization may protect against COVID-19. Med Hypotheses

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

74. multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia

Zhonghua Jie He He Hu Xi Za Zhi